Elbit Imaging of Tel Aviv, Israel, has unveiled plans to consolidate its biotech and medical holdings into one wholly owned subsidiary.
The action would bring focused-ultrasound developer InSightec of Tirat Carmel, Israel, and therapeutic stem cell developer Gamida Cell of Jerusalem into one entity to streamline business activities.
Elbit Imaging also would offer shares of the subsidiary in a public offering on the Tel Aviv Stock Exchange.
Related Reading
InSightec gets Japanese clearance, January 13, 2010
Study: InSightec's ExAblate helps with pain, July 14, 2009
InSightec notches $15 million investment, March 19, 2009
InSightec raises $30 million, November 30, 2007
InSightec proceeds with phase I trial, September 26, 2007
Copyright © 2010 AuntMinnie.com
.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=100&q=70&w=100)
.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=167&q=70&w=250)
